CUE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.24%

Insider Buying (Last 12 Months): $19,620.00

Insider Selling (Last 12 Months): $0.00

Cue Biopharma Insider Trading History Chart

Cue Biopharma Share Price & Price History

^$1.56

▼ -0.02 (-1.27%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Urgent alert: open this for a huge profit potential

From Timothy Sykes | Ad

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

Cue Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/25/2023	Anish Suri	Insider	Buy	4,000	$2.76	$11,040.00	135,638
8/14/2023	Daniel R. Passeri	CEO	Buy	3,000	$2.86	$8,580.00	134,578
3/23/2023	Peter A Kiener	Director	Sell	9,325	$3.28	$30,586.00	357
5/23/2022	Aaron G.L. Fletcher	Director	Buy	150,000	$3.52	$528,000.00	885,000
3/31/2022	Aaron G.L. Fletcher	Director	Buy	735,000	$4.76	$3,498,600.00	165,000
10/1/2021	Kerri-Ann Millar	CFO	Sell	1,251	$14.21	$17,776.71
9/24/2021	Daniel R. Passeri	CEO	Buy	3,400	$14.72	$50,048.00
9/23/2021	Anish Suri	Insider	Sell	20,000	$15.23	$304,600.00

Urgent alert: open this for a huge profit potential

From Timothy Sykes | Ad

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

SEC Filings (Institutional Ownership Changes) for Cue Biopharma (NASDAQ:CUE)

35.04% of Cue Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cue Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/10/2024	Wedmont Private Capital	40,000	$76K	0.0%	+100.0%	0.082%
3/11/2024	Vanguard Group Inc.	2,132,905	$5.63M	0.0%	+0.4%	4.727%
3/1/2024	Goldman Sachs Group Inc.	58,324	$0.15M	0.0%	+205.2%	0.129%
2/16/2024	GSA Capital Partners LLP	13,952	$37K	0.0%	N/A	0.031%
2/15/2024	Barclays PLC	55,529	$0.15M	0.0%	+362.2%	0.123%
2/15/2024	Vanguard Group Inc.	2,132,905	$5.63M	0.0%	+0.4%	4.727%
2/15/2024	Occudo Quantitative Strategies LP	33,439	$88K	0.0%	N/A	0.074%
2/13/2024	Northern Trust Corp	381,367	$1.01M	0.0%	+16.0%	0.845%
2/13/2024	Goldman Sachs Group Inc.	58,324	$0.15M	0.0%	+205.2%	0.129%
2/12/2024	Stifel Financial Corp	193,975	$0.51M	0.0%	+31.8%	0.430%
2/9/2024	UBS Group AG	99,261	$0.26M	0.0%	+25.4%	0.220%
2/8/2024	Legacy Capital Group California Inc.	10,000	$26K	0.0%	N/A	0.022%
2/7/2024	Dimensional Fund Advisors LP	457,985	$1.21M	0.0%	-19.2%	1.015%
2/7/2024	BNP Paribas Financial Markets	16,724	$44K	0.0%	-22.9%	0.037%
2/7/2024	Monaco Asset Management SAM	342,242	$0.90M	0.3%	-4.9%	0.759%
2/6/2024	Charles Schwab Investment Management Inc.	105,691	$0.28M	0.0%	+10.0%	0.234%
2/1/2024	Sigma Planning Corp	108,875	$0.29M	0.0%	-55.5%	0.241%
1/18/2024	Navalign LLC	25,000	$66K	0.0%	N/A	0.055%
1/18/2024	Good Life Advisors LLC	100,000	$0.26M	0.0%	-10.7%	0.222%
12/18/2023	Vanguard Group Inc.	2,124,906	$4.89M	0.0%	+3.7%	4.709%
11/30/2023	American Century Companies Inc.	21,758	$50K	0.0%	+80.6%	0.048%
11/16/2023	Wolverine Trading LLC	11,128	$26K	0.0%	N/A	0.025%
11/15/2023	AQR Capital Management LLC	23,877	$55K	0.0%	N/A	0.053%
11/7/2023	Monaco Asset Management SAM	359,739	$0.83M	0.2%	-2.9%	0.800%
11/7/2023	New York State Common Retirement Fund	11,984	$28K	0.0%	-53.4%	0.027%
11/6/2023	Sigma Planning Corp	244,705	$0.56M	0.0%	+8.6%	0.544%
10/24/2023	Channel Wealth LLC	15,300	$35K	0.0%	-77.7%	0.034%
10/13/2023	Sanders Morris Harris LLC	346,212	$0.80M	0.2%	+513.6%	0.770%
9/21/2023	Barclays PLC	12,946	$48K	0.0%	+114.7%	0.029%
8/21/2023	California State Teachers Retirement System	11,497	$42K	0.0%	N/A	0.026%
8/16/2023	Nuveen Asset Management LLC	146,326	$0.53M	0.0%	N/A	0.325%
8/15/2023	Wells Fargo & Company MN	69,560	$0.25M	0.0%	+35.5%	0.155%
8/15/2023	Goldman Sachs Group Inc.	17,607	$64K	0.0%	+26.5%	0.039%
8/15/2023	Silverarc Capital Management LLC	403,402	$1.47M	0.5%	+31.7%	0.897%
8/14/2023	State Street Corp	651,295	$2.38M	0.0%	+361.4%	1.449%
8/14/2023	Nuveen Asset Management LLC	146,326	$0.53M	0.0%	N/A	0.325%
8/11/2023	Renaissance Technologies LLC	155,000	$0.57M	0.0%	+203.3%	0.345%
8/11/2023	BlackRock Inc.	2,066,074	$7.54M	0.0%	+211.0%	4.595%
8/11/2023	Geode Capital Management LLC	729,445	$2.66M	0.0%	+61.1%	1.622%
8/11/2023	JPMorgan Chase & Co.	27,581	$0.10M	0.0%	+70,620.5%	0.061%
8/11/2023	Northern Trust Corp	331,435	$1.21M	0.0%	+323.3%	0.737%
8/10/2023	MetLife Investment Management LLC	18,510	$68K	0.0%	N/A	0.043%
8/10/2023	Carlson Capital L P	134,036	$0.49M	0.0%	-47.2%	0.310%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	21,036	$77K	0.0%	N/A	0.049%
8/10/2023	Charles Schwab Investment Management Inc.	96,080	$0.35M	0.0%	+268.3%	0.223%
8/10/2023	Citigroup Inc.	10,292	$38K	0.0%	N/A	0.024%
8/9/2023	Dimensional Fund Advisors LP	555,239	$2.03M	0.0%	+1.8%	1.286%
8/9/2023	BNP Paribas Arbitrage SNC	9,089	$33K	0.0%	+9,270.1%	0.021%
8/8/2023	Monaco Asset Management SAM	370,407	$1.35M	0.4%	-20.6%	0.858%
8/4/2023	American International Group Inc.	16,635	$61K	0.0%	N/A	0.039%
8/3/2023	Barclays PLC	12,946	$48K	0.0%	+114.7%	0.030%
8/3/2023	Bank of New York Mellon Corp	103,154	$0.38M	0.0%	+384.6%	0.239%
8/2/2023	Sigma Planning Corp	225,300	$0.82M	0.0%	+2.0%	0.522%
7/27/2023	Virtu Financial LLC	17,594	$64K	0.0%	N/A	0.041%
7/26/2023	Channel Wealth LLC	68,700	$0.25M	0.1%	+14.4%	0.159%
7/13/2023	Cambridge Investment Research Advisors Inc.	20,000	$73K	0.0%	N/A	0.046%
7/11/2023	Sanders Morris Harris LLC	56,420	$0.20M	0.0%	N/A	0.131%
5/16/2023	Susquehanna International Group LLP	132,535	$0.47M	0.0%	+350.8%	0.307%
5/16/2023	Jane Street Group LLC	26,974	$96K	0.0%	N/A	0.062%
5/16/2023	Squarepoint Ops LLC	20,233	$72K	0.0%	N/A	0.047%
5/16/2023	Geode Capital Management LLC	452,768	$1.62M	0.0%	+43.4%	1.049%
5/15/2023	Two Sigma Advisers LP	33,100	$0.12M	0.0%	-69.6%	0.077%
5/12/2023	Renaissance Technologies LLC	51,100	$0.18M	0.0%	-63.9%	0.118%
5/12/2023	Stifel Financial Corp	146,464	$0.52M	0.0%	+12.4%	0.339%
5/12/2023	Prosight Management LP	1,151,855	$4.11M	1.9%	-37.4%	2.668%
5/12/2023	BlackRock Inc.	664,426	$2.37M	0.0%	-5.4%	1.539%
5/12/2023	Bank of America Corp DE	167,495	$0.60M	0.0%	+72.6%	0.388%
5/12/2023	UBS Group AG	58,029	$0.21M	0.0%	+140.3%	0.134%
5/12/2023	Dimensional Fund Advisors LP	545,624	$1.95M	0.0%	+19.2%	1.264%
5/12/2023	Charles Schwab Investment Management Inc.	26,084	$93K	0.0%	+106.2%	0.060%
5/12/2023	HighTower Advisors LLC	76,110	$0.27M	0.0%	N/A	0.176%
5/8/2023	Sigma Planning Corp	220,889	$0.79M	0.0%	+14.6%	0.512%
5/1/2023	P.A.W. Capital Corp	150,000	$0.54M	1.2%	-16.7%	0.347%
4/27/2023	Channel Wealth LLC	60,050	$0.21M	0.1%	N/A	0.139%
4/18/2023	ETF Managers Group LLC	13,528	$48K	0.0%	N/A	0.031%
2/15/2023	Silverarc Capital Management LLC	306,278	$0.87M	0.2%	N/A	0.712%
2/15/2023	Millennium Management LLC	373,982	$1.07M	0.0%	-15.1%	0.869%
2/15/2023	Morgan Stanley	178,796	$0.51M	0.0%	-30.0%	0.415%
2/13/2023	Voss Capital LLC	125,000	$0.36M	0.1%	-37.5%	0.290%
2/13/2023	Wells Fargo & Company MN	48,121	$0.14M	0.0%	+140.5%	0.112%
2/13/2023	Renaissance Technologies LLC	141,700	$0.40M	0.0%	-66.7%	0.329%
2/13/2023	Geode Capital Management LLC	315,827	$0.90M	0.0%	+5.8%	0.734%
2/13/2023	GSA Capital Partners LLP	188,308	$0.54M	0.1%	-12.9%	0.438%
2/10/2023	Good Life Advisors LLC	75,000	$0.21M	0.0%	+31.6%	0.174%
2/10/2023	Bank of America Corp DE	97,034	$0.28M	0.0%	-14.5%	0.225%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	22,970	$65K	0.0%	-29.7%	0.053%
2/9/2023	Dimensional Fund Advisors LP	457,667	$1.31M	0.0%	+0.8%	1.063%
2/3/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
2/1/2023	Bank of Montreal Can	33,900	$98K	0.0%	N/A	0.079%
1/31/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
1/24/2023	Sigma Planning Corp	192,734	$0.55M	0.0%	+2.3%	0.448%
1/13/2023	Sanders Morris Harris LLC	56,420	$0.16M	0.1%	-93.3%	0.131%
11/15/2022	State Street Corp	141,153	$0.32M	0.0%	-11.0%	0.399%
11/15/2022	Two Sigma Advisers LP	183,300	$0.41M	0.0%	-14.4%	0.518%
11/15/2022	Two Sigma Investments LP	34,102	$76K	0.0%	-73.9%	0.096%
11/15/2022	Prosight Management LP	1,545,573	$3.45M	1.8%	-6.6%	4.368%
11/15/2022	Marshall Wace LLP	26,205	$58K	0.0%	-51.4%	0.074%
11/15/2022	BlackRock Inc.	778,708	$1.74M	0.0%	-6.4%	2.201%
11/15/2022	Carlson Capital L P	535,000	$1.19M	0.1%	-7.8%	1.512%
11/14/2022	Annandale Capital LLC	65,000	$0.15M	0.1%	N/A	0.184%

Data available starting January 2016

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $1.56

$1.52

$1.61

50 Day Range

MA: $1.95

$1.50

$2.55

52 Week Range

Now: $1.56

$1.47

$5.12

Volume

169,010 shs

Average Volume

268,170 shs

Market Capitalization

$75.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.02

Who are the company insiders with the largest holdings of Cue Biopharma?: Cue Biopharma's top insider investors include:
Aaron GL Fletcher (Director)
Anish Suri (Insider)
Daniel R Passeri (CEO)
Peter A Kiener (Director)
Learn More about top insider investors at Cue Biopharma.
Who are the major institutional investors of Cue Biopharma?: Cue Biopharma's top institutional investors include:
Wedmont Private Capital — 0.08%
Learn More about top institutional investors of Cue Biopharma stock.
Which institutional investors are buying Cue Biopharma stock?: In the last quarter, CUE stock was bought by institutional investors including:
Wedmont Private Capital
Within the last year, these company insiders have bought Cue Biopharma stock:
Aaron GL Fletcher (Director)
Anish Suri (Insider)
Daniel R Passeri (CEO)
Learn More investors buying Cue Biopharma stock.